• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Turnstone Biologics

layoffs cut staff reduction workforce
Biotech

Turnstone ends final TIL program over costs, plots more layoffs

Four months after laying off 60% of its workforce, Turnstone is planning further redundancies after giving up on its final clinical-stage candidate.
James Waldron Feb 4, 2025 10:30am
A series of dice with a bag on them illustrating cost cuts

Turnstone lays off 60%, shakes up C-suite to stretch out cash

Oct 11, 2024 8:05am
target reach ladder climb meet win beat competition

Turnstone narrows cell therapy focus to 'high unmet need' tumors

Aug 15, 2024 7:46am
Wall Street stock exchange finance shares share price Nasdaq

Turnstone turns fortunes around with $80M IPO haul

Jul 21, 2023 9:25am
Nasdaq

Booted by Big Pharma, Turnstone files IPO to fund cell therapies

Jun 13, 2023 9:40am
Takeda HQ

Takeda cuts ties to cancer drug landed in $120M Turnstone deal

Jul 28, 2022 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings